Apply for the Servier Golden Ticket 2025 – a unique opportunity to accelerate your research and development efforts
Applications are now open for the Servier Golden Ticket – a program sponsored by Servier in collaboration with SmiLe Venture Hub, designed to support a promising startup in oncology and neuroscience, developing groundbreaking therapeutics, platform technologies or AI/ML data-driven platforms for drug discovery.
Servier is a leading French pharmaceutical company, ranked 35th globally and 2nd in France. It operates in over 150 countries, with 22,000 employees and a strong focus on innovation and scientific advancement.
The Servier Golden Ticket winner will receive one year of access to a lab bench and office space at SmiLe Venture Hub in Lund, state-of-the-art facilities and equipment, mentorship and business coaching from SmiLe, direct engagement with Servier’s scientific experts and industry advisors, and exclusive access to both Servier’s and SmiLe’s networks.
The application deadline is May 1, 2025.
Read more and apply at: smileventurehub.com/servier-golden-ticket
For questions, contact:
Thomas Areschoug, Business Coach and Head of Industry Relations at SmiLe Venture Hub
thomas.areschoug@smileventurehub.com
About SmiLe Venture Hub – Pioneering Life Science and Foodtech Innovations
SmiLe is a leading venture hub that specializes in advancing life science and foodtech startups from concept to commercialization. We offer comprehensive support through every stage of entrepreneurship, including tailored incubation and acceleration programs, a variety of educational courses, and access to top-tier lab facilities. To date, our flagship incubator program has supported over 110 startups, facilitating their collective acquisition of more than EUR 1.05 billion in venture capital and contributing to 21 successful IPOs. Recognized as one of Europe’s leading startup hubs in 2024 by the Financial Times and Statista, SmiLe continues to be a catalyst for innovation in the life sciences sector. As a non-profit entity based in Lund, Sweden, SmiLe is supported by Region Skåne, Lund Municipality, Lund University, and Medicon Village. We are also backed by our partners Agilent, Sparbanken Skåne, Høiberg, Setterwalls, Zacco, Key2Compliance, Phase Holographic Imaging, ChemoMetec, Samplix, Qiagen, Merck, Bio-Rad, Zeiss, SmartStone Nordics, and AbbVie Scandinavia. For more information: www.smileventurehub.com
Powered by Notified